TegoScience Inc. (KOSDAQ:191420)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,920
+180 (1.41%)
At close: Mar 6, 2026
-20.25%
Market Cap 93.04B
Revenue (ttm) 6.15B
Net Income (ttm) -3.25B
Shares Out 8.01M
EPS (ttm) -406.28
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,291
Average Volume 18,003
Open 12,620
Previous Close 12,740
Day's Range 12,450 - 13,000
52-Week Range 11,500 - 20,250
Beta 0.87
RSI 28.10
Earnings Date Nov 14, 2025

About TegoScience

TegoScience Inc., a biotechnology-based cosmetics company, engages in the production of various skin cell therapy products originating from human epithelial cells in South Korea. The company offers Holoderm, a commercialized cultured skin autograft; Kaloderm, an allogeneic cell therapy product for healing wounds; Rosmir, a fibroblast cell therapy; and Neoderm, a three-dimensionally cultured skin model. It also provides KCM for skin regeneration effect; Chemotide, a single-chain human peptide; contract research services, such as biologics qualit... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 191420
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.